Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States
Clinical trial NCT06747273 · TERMINATED
Trial details
- NCT number
- NCT06747273
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-09
- Primary completion
- 2025-06-18
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.